<p><sup>*</sup>One outlier from the Latin American region (HIV Prevalence: 0.20, Prevalence Ratio: 45) is not presented.</p
<p>Point estimates are presented with 95% binomial exact confidence intervals (CI). The estimated tr...
Background: Transmitted drug resistance (TDR) remains an important concern for the management of HIV...
<p>Data are median (IQR) of study-level prevalence of individuals with any (overall) and NRTI-, NNRT...
*<p>includes patients with unknown HIV status.</p>**<p>all patients have unknown HIV status.</p
TB prevalence by country, comparing individuals who self-reported they were HIV–positive and taking ...
<p>TB prevalence in different patient groups stratified by HIV status (HIV status was available for ...
<p>Pooled HIV prevalence by country among studies reporting biologically-confirmed HIV prevalence wi...
TB prevalence by country and HIV status, overall and stratified by sex and age group.</p
<div><p>Bars are divided into smear-positive (dark portion) and smear-negative culture-positive TB (...
<p>The prevalence of HIV among MSM in Malawi, Namibia, and Botswana and proportion aware of serostat...
<p>Measured Prevalence of HIV, Latent Tuberculosis, and Syphilis in Study Group Compared to Health D...
<p>(Argentina was excluded from this analysis due to limited power). <sup>a</sup>adjusted for gender...
Transmitted drug resistance (TDR) remains an important concern for the management of HIV infection, ...
<p>Disaggregated prevalence of MDR-TB by study attributes and their measure of heterogeneity.</p
1<p>Among studies confirming HIV infection with a biological assay and among studies reporting ≥50 p...
<p>Point estimates are presented with 95% binomial exact confidence intervals (CI). The estimated tr...
Background: Transmitted drug resistance (TDR) remains an important concern for the management of HIV...
<p>Data are median (IQR) of study-level prevalence of individuals with any (overall) and NRTI-, NNRT...
*<p>includes patients with unknown HIV status.</p>**<p>all patients have unknown HIV status.</p
TB prevalence by country, comparing individuals who self-reported they were HIV–positive and taking ...
<p>TB prevalence in different patient groups stratified by HIV status (HIV status was available for ...
<p>Pooled HIV prevalence by country among studies reporting biologically-confirmed HIV prevalence wi...
TB prevalence by country and HIV status, overall and stratified by sex and age group.</p
<div><p>Bars are divided into smear-positive (dark portion) and smear-negative culture-positive TB (...
<p>The prevalence of HIV among MSM in Malawi, Namibia, and Botswana and proportion aware of serostat...
<p>Measured Prevalence of HIV, Latent Tuberculosis, and Syphilis in Study Group Compared to Health D...
<p>(Argentina was excluded from this analysis due to limited power). <sup>a</sup>adjusted for gender...
Transmitted drug resistance (TDR) remains an important concern for the management of HIV infection, ...
<p>Disaggregated prevalence of MDR-TB by study attributes and their measure of heterogeneity.</p
1<p>Among studies confirming HIV infection with a biological assay and among studies reporting ≥50 p...
<p>Point estimates are presented with 95% binomial exact confidence intervals (CI). The estimated tr...
Background: Transmitted drug resistance (TDR) remains an important concern for the management of HIV...
<p>Data are median (IQR) of study-level prevalence of individuals with any (overall) and NRTI-, NNRT...
DOI
Add to ORKG